The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.


Updates from The Motley Fool

Latest updates on Trinity Biotech from Fool.com.


Stock Performance

TRIB vs. S&P 500 | 2 Year Performance
View Interactive TRIB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Trinity Biotech.
Current Price: $12.43
Prev Close: $12.40
Open: $12.30
Bid: $8.12
Ask: $24.00
Day's Range: $12.05 - $12.49
52wk Range: $9.20 - $18.55
Volume: 34,903
Avg Vol 54,580
Market Cap: $293.06M
P/E (ttm): 29.52
EPS (ttm): $0.00
Div & Yield: $0.22 (0.0%)

Company Rating

What our community thinks about Trinity Biotech.
CAPS Rating 3 out of 5
 
138 Outperform
10 Underperform
CAPS All Stars
 
21 Outperform
1 Underperform

How do you think Trinity Biotech will perform against the market?



You pick for Trinity Biotech is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Trinity Biotech.

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers